Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Deferred Taxes (2020 - 2026)

Bioventus filings provide 6 years of Deferred Taxes readings, the most recent being -$1.1 million for Q4 2025.

  • On a quarterly basis, Deferred Taxes fell 135.18% to -$1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$909000.0, a 83.15% increase, with the full-year FY2025 number at -$909000.0, up 83.15% from a year prior.
  • Deferred Taxes hit -$1.1 million in Q4 2025 for Bioventus, down from $135000.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $3.2 million in Q4 2024 to a low of -$17.0 million in Q2 2022.
  • Median Deferred Taxes over the past 5 years was -$876000.0 (2023), compared with a mean of -$3.4 million.
  • Biggest five-year swings in Deferred Taxes: crashed 20603.61% in 2022 and later soared 176.44% in 2024.
  • Bioventus' Deferred Taxes stood at -$8.1 million in 2021, then tumbled by 46.14% to -$11.8 million in 2022, then soared by 109.88% to $1.2 million in 2023, then surged by 176.44% to $3.2 million in 2024, then tumbled by 135.18% to -$1.1 million in 2025.
  • The last three reported values for Deferred Taxes were -$1.1 million (Q4 2025), $135000.0 (Q3 2025), and $44000.0 (Q2 2025) per Business Quant data.